Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece
George Gourzoulidis, C. Tzanetakos, Ioannis Ioannidis, Vasilis Tsimihodimos, Viana Diogo, George Karpouzos, Giannis Papageorgiou, Georgia Kourlaba
Topics & Concepts
DapagliflozinEmpagliflozinMedicinePharmacotherapyDiabetes mellitusDiseaseType 2 Diabetes MellitusIntensive care medicineType 2 diabetesBenzhydryl compoundsInternal medicineEndocrinologyEpoxyChemistryBisphenol AOrganic chemistryDiabetes Treatment and ManagementDiabetes Management and ResearchHyperglycemia and glycemic control in critically ill and hospitalized patients